S-1/A: Jackson Acquisition Company II Files Amendment for $200 Million IPO Targeting Healthcare Sector

Jackson Acquisition Company II, a blank check company, has filed an amendment to its registration statement for a $200 million initial public offering, with a focus on acquiring businesses in the healthcare services and technology sectors.

Summary

• Jackson Acquisition Company II is a newly formed blank check company aiming to merge with a healthcare-focused business.
• The company plans to raise $200 million through an IPO, offering 20 million units at $10.00 each, with an additional 3 million units available through an underwriter over-allotment option.
• Each unit includes one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon a business combination.
• The funds will be held in a U.S.-based trust account, with $201 million (or $231.2 million if the over-allotment option is exercised) to be deposited.
• The company intends to focus on healthcare services and technology businesses, leveraging its management's experience in the sector.
• The company has 24 months to complete a business combination, or it will liquidate and return funds to shareholders.
• The sponsor and underwriter have agreed to purchase 650,000 private placement units for $6.5 million, or 725,000 units for $7.25 million if the over-allotment option is exercised.
• The company's sponsor will receive 5,750,000 Class B ordinary shares for a nominal price of $25,000, which will convert to Class A ordinary shares upon a business combination.
• The company will pay a marketing fee of up to 4% of the gross proceeds of the offering to the underwriter upon the consummation of a business combination.

Sentiment

Score: 7

Explanation: The document is generally positive, outlining a clear plan for an IPO and a focus on a growing sector. However, it also acknowledges the risks associated with blank check companies and the potential for dilution, which tempers the overall sentiment.

Positives

• The company's management team has extensive experience in the healthcare services sector.
• The company is targeting a large and growing market with strong secular tailwinds.
• The company has the flexibility to use cash, shares, or debt to complete a business combination.
• The company is positioned to capitalize on key trends and opportunities in the healthcare industry.
• The company intends to focus on private healthcare services companies that would benefit from a public listing.

Negatives

• The company is a blank check company with no operating history or revenues.
• The company has a limited time frame of 24 months to complete a business combination.
• The company's sponsor will receive a significant number of shares for a nominal price, which may result in dilution for public shareholders.
• The company may need to raise additional funds to complete a business combination, which could lead to further dilution.
• The company's management team may have conflicts of interest in selecting a target business.
• The company may be deemed to be a passive foreign investment company, or PFIC, which could result in adverse U.S. federal income tax consequences to U.S. investors.

Risks

• The company may not be able to complete a business combination within the 24-month timeframe.
• The company may not be able to find a suitable target business.
• The company may be subject to claims from third parties, which could reduce the funds available in the trust account.
• The company may be deemed to be an investment company under the Investment Company Act.
• The company's management team may have conflicts of interest in selecting a target business.
• The company may be subject to regulatory review and approval requirements by governmental entities, or ultimately prohibited.
• The company may be materially adversely affected by current global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas conflict.
• The company may be a passive foreign investment company, or PFIC, which could result in adverse U.S. federal income tax consequences to U.S. investors.

Future Outlook

The company intends to complete a business combination within 24 months, focusing on healthcare services and technology businesses. The company may seek to raise additional funds through a private offering of debt or equity securities in connection with the completion of its initial business combination.

Management Comments

• We intend to capitalize on the ability of our management team and board of directors to identify, acquire and operate businesses across a range of sectors that may provide opportunities for attractive long-term risk-adjusted returns.
• We believe that the healthcare services industry will continue to grow significantly due to, among other things, the increased use of innovative technologies designed to improve patient outcomes, drive efficiency in the industry and permit healthcare companies to better control costs while improving access and overall quality of healthcare.
• We believe that, in recent years, private healthcare services companies have not had easy access to the U.S. initial public offering (IPO) markets.

Industry Context

This announcement comes amid a growing trend of SPACs targeting the healthcare sector, which is seen as a large and growing market with strong secular tailwinds. The company's focus on private healthcare services companies aligns with the current market conditions where such companies have limited access to public capital.

Comparison to Industry Standards

• The structure of Jackson Acquisition Company II is similar to other blank check companies, also known as special purpose acquisition companies (SPACs), that have recently gone public.
• The 24-month timeframe to complete a business combination is a common feature among SPACs.
• The inclusion of a right to receive a fraction of a share upon a business combination is a common feature of SPACs.
• The 80% fair market value test is a standard requirement for SPACs listed on the NYSE.
• The lock-up periods for founder shares and private placement units are also typical for SPACs.
• The marketing fee of up to 4% of the gross proceeds is within the range of fees charged by underwriters in similar transactions.
• The redemption rights offered to public shareholders are also a standard feature of SPACs.

Related Party Transactions

• The company's sponsor paid $25,000 for founder shares.
• The company will pay an affiliate of the sponsor $10,000 per month for office space and administrative services.
• The company may repay loans from the sponsor or its affiliates for transaction costs.
• The company's sponsor and underwriter will purchase private placement units for $6.5 million, or $7.25 million if the over-allotment option is exercised.

Stakeholder Impact

• Shareholders will have the opportunity to redeem their shares upon completion of a business combination.
• Shareholders may experience dilution due to the issuance of founder shares and potential additional equity issuances.
• Shareholders will have the opportunity to vote on a proposed business combination, if required.
• Employees of a target business may be affected by the terms of the business combination.
• Customers and suppliers of a target business may be affected by the terms of the business combination.

Next Steps

• The company will seek to identify and evaluate potential target businesses.
• The company will negotiate and enter into a definitive agreement for a business combination.
• The company will seek shareholder approval for the business combination, if required.
• The company will complete the business combination within 24 months.
• The company will file a Current Report on Form 8-K with the SEC to announce the separate trading of Class A ordinary shares and public rights.

Key Dates

Keywords

blank check company, SPAC, healthcare services, healthcare technology, initial public offering, IPO, business combination, merger, acquisition, trust account, private placement, redemption rights